Organogenesis recommends CMS also implement an integrated coverage and payment policyCANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading ...

We'll examine a selection from our screener results. Overview: Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes products for advanced ...

Organogenesis Price Performance NASDAQ ORGO opened at $4.26 on Friday. The company has a current ratio of 3.09, a quick ratio of 2.74 and a debt-to-equity ratio of 0.21. Organogenesis Holdings Inc ...